<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d232">
    <sentence id="DDI-DrugBank.d232.s0" text="After multiple dosing, interferon beta-1a (AVONEX  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.">
        <entity id="DDI-DrugBank.d232.s0.e0" charOffset="23-40"
            type="drug" text="interferon beta-1a"/>
        <entity id="DDI-DrugBank.d232.s0.e1" charOffset="43-48"
            type="brand" text="AVONEX"/>
        <entity id="DDI-DrugBank.d232.s0.e2" charOffset="82-88"
            type="brand" text="TYSABRI"/>
        <ddi id="DDI-DrugBank.d232.s0.d0" e1="DDI-DrugBank.d232.s0.e0"
            e2="DDI-DrugBank.d232.s0.e2" type="mechanism"/>
        <ddi id="DDI-DrugBank.d232.s0.d1" e1="DDI-DrugBank.d232.s0.e1"
            e2="DDI-DrugBank.d232.s0.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d232.s1" text="The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).">
        <entity id="DDI-DrugBank.d232.s1.e0" charOffset="22-28"
            type="brand" text="TYSABRI"/>
        <entity id="DDI-DrugBank.d232.s1.e1" charOffset="105-110"
            type="brand" text="AVONEX"/>
        <entity id="DDI-DrugBank.d232.s1.e2" charOffset="148-153"
            type="brand" text="AVONEX"/>
        <entity id="DDI-DrugBank.d232.s1.e3" charOffset="239-245"
            type="brand" text="TYSABRI"/>
    </sentence>
    <sentence id="DDI-DrugBank.d232.s2" text="Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.">
        <entity id="DDI-DrugBank.d232.s2.e0" charOffset="57-63"
            type="brand" text="TYSABRI"/>
        <entity id="DDI-DrugBank.d232.s2.e1" charOffset="82-99"
            type="drug" text="interferon beta-1a"/>
        <entity id="DDI-DrugBank.d232.s2.e2" charOffset="102-107"
            type="brand" text="AVONEX"/>
        <entity id="DDI-DrugBank.d232.s2.e3" charOffset="136-153"
            type="drug" text="glatiramer acetate"/>
        <entity id="DDI-DrugBank.d232.s2.e4" charOffset="224-238"
            type="drug" text="beta-interferon"/>
        <entity id="DDI-DrugBank.d232.s2.e5" charOffset="243-260"
            type="drug" text="glatiramer acetate"/>
    </sentence>
</document>
